Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant

Annals of Occupational Hygiene

Volumn 56, Issue 9, 2012, Pages 1025-1037

  Woskie, Susan R ^a   Gore, Rebecca ^a   Steenland, Kyle ^b  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Exposure assessment; Exposure determinants; Exposure science; Historical exposure assessment; Retrospective exposure assessment exposure metric; Teflon

Indexed keywords

CHOLESTEROL LEVELS; CUBIC SPLINE FUNCTIONS; DATA COMPARISONS; EPIDEMIOLOGIC-STUDY; EXPOSURE ASSESSMENT; EXPOSURE DETERMINANTS; EXPOSURE SCIENCE; FLUOROPOLYMER; HUMAN CARCINOGEN; LINEAR MIXED MODELS; MANUFACTURING PLANT; PERFLUOROOCTANOIC ACID; PROCESS CHANGE; REPEATED MEASURES; SERUM CONCENTRATION; SERUM LEVELS; SPEARMAN CORRELATION; WEST VIRGINIA;

AUTOMOBILE MANUFACTURE; FLUORINE CONTAINING POLYMERS; MAMMALS; POLYTETRAFLUOROETHYLENES;

BODY FLUIDS;

FLUOROCARBON; OCTANOIC ACID DERIVATIVE; PERFLUOROOCTANOIC ACID; POLITEF;

ARTICLE; COHORT ANALYSIS; HUMAN; INDUSTRY; OCCUPATIONAL EXPOSURE; RETROSPECTIVE STUDY; THEORETICAL MODEL; UNITED STATES;

CAPRYLATES; COHORT STUDIES; FLUOROCARBONS; HUMANS; INDUSTRY; MODELS, THEORETICAL; OCCUPATIONAL EXPOSURE; POLYTETRAFLUOROETHYLENE; RETROSPECTIVE STUDIES; WEST VIRGINIA;

EID: 84869003076     PISSN: 00034878     EISSN: 14753162     Source Type: Journal    
DOI: 10.1093/annhyg/mes023     Document Type: Article

References (38)

1. Armstrong BG. (1990) The effects of measurement errors on relative risk regressions. Am J Epidemiol; 132: 1176-84.
2. Blair A, Stewart P, Lubin JH et al. (2007) Methodological issues regarding confounding and exposure misclassification in epidemiological studies of occupational exposures. Am J Ind Med; 50: 199-207.
3. Calafat AM, Kuklenyik Z, Reidy JA et al. (2007) Serumconcentrations of 11 polyfluoroalkyl compounds in the U.S. population: data from the national health and nutrition examination survey (nhanes). Environ Sci Technol; 41: 2237-42.
4. Dosemeci M, Wacholder S, Lubin JH. (1990) Does nondifferential misclassification of exposure always bias the true effect toward the null? Am J Epidemiol; 105: 746-8.
5. Ehresman DJ, Froehlich JW, Olsen GWet al. (2007) Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (pfos), perfluorooctanoate (pfoa), and other fluorochemicals. Environ Res; 103: 176-84.
6. Emmett EA, Zhang H, Shofer FS et al. (2006) Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med; 48: 771-9.
7. Han X, Snow TA, Kemper RA et al. (2003) Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol; 16: 775-81.
8. Harrell FE. (2001) Regression modeling strategies. New York, NY: Springer-Verlag.
9. Harrell FE Jr, Lee KL, Pollock BG. (1988) Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst; 80: 1198-202.
10. Hines CJ, Deddens JA, Lu C et al. (2006) Mixed-effect models for evaluating multiple measures of atrazine exposure among custom applicators. J Occup Environ Hyg; 3: 274-83.
11. Jones PD, Hu W, De Coen Wet al. (2003) Binding of perfluorinated fatty acids to serum proteins. Environ Toxicol Chem; 22: 2639-49.
12. Karrman A, van Bavel B, Jarnberg U et al. (2006) Perfluorinated chemicals in relation to other persistent organic pollutants in human blood. Chemosphere; 64: 1582-91.
13. Kato K, Basden BJ, Needham LL et al. (2011) Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals. J Chromatogr A; 1218: 2133-7.
14. Kreckmann KH, Sakr CJ, Leonard RC et al. (2009) Estimation and validation of biomarker-based exposures for historical ammonium perfluorooctanoate. J Occup Environ Hyg; 6: 511-6.
15. Leonard RC, Kreckmann KH, Sakr CJ et al. (2008) Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol; 18: 15-22.
16. Lin YS, Kupper LL, Rappaport SM. (2005) Air samples versus biomarkers for epidemiology. Occup Environ Med; 62: 750-60.
17. Lundin JI, Alexander BH, Olsen GWet al. (2009) Ammonium perfluorooctanoate production and occupational mortality. Epidemiology; 20: 921-8.
18. McClean MD, Rinehart RD, Ngo L et al. (2004) Inhalation and dermal exposure among asphalt paving workers. Ann Occup Hyg; 48: 663-71.
19. Olsen GW, Burris JM, Burlew MM et al. (2000) Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem Toxicol; 23: 603-20.
20. Olsen GW, Burris JM, Burlew MM et al. (2003) Epidemiologic assessment of worker serum perfluorooctanesulfonate (pfos) and perfluorooctanoate (pfoa) concentrations and medical surveillance examinations. J Occup Environ Med; 45: 260-70.
21. Olsen GW, Burris JM, Ehresman DJ et al. (2007) Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect; 115: 1298-305.
22. Olsen GW, Zobel LR. (2007) Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (pfoa) concentrations in fluorochemical production workers. Int Arch Occup Environ Health; 81: 231-46.
23. Paustenbach DJ, Panko JM, Scott PK et al. (2007) A methodology for estimating human exposure to perfluorooctanoic acid (pfoa): a retrospective exposure assessment of a community (1951-2003). J Toxicol Environ Health A; 70: 28-57.
24. Peretz C, Goren A, Smid T et al. (2002) Application of mixedeffects models for exposure assessment. Ann Occup Hyg; 46: 69-77.
25. Sakr CJ, Kreckmann KH, Green JW et al. (2007a) Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or apfo) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med; 49: 1086-96.
26. Sakr CJ, Leonard RC, Kreckmann KH et al. (2007b) Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med; 49: 872-9.
27. Sakr CJ, Symons JM, Kreckmann KH et al. (2009) Ischaemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate. Occup Environ Med; 66: 699-703.
28. Seals R, Bartell SM, Steenland K. (2011) Accumulation and clearance of perfluorooctanoic acid (pfoa) in current and former residents of an exposed community. Environ Health Perspect; 119: 119-24.
29. Shin H-M, Vieira V, Ryan PB et al. (2011a) Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington works facility in West Virginia. Environ Sci Technol; 45: 1435-42.
30. Shin H-M, Vieira VM, Ryan PB et al. (2011b) Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the c8 health project. Environ Health Perspect; 119: 1760-1765.
31. Steenland K, Deddens J, Piacitelli L. (2001) Risk assessment for 2,3,7,8-tetrachlorodibenzo-p-dioxin (tcdd) based on an epidemiologic study. Am J Epidemiol; 154: 451-8.
32. Steenland K, Deddens JA, Zhao S. (2000) Biases in estimating the effect of cumulative exposure in log-linear models when estimated exposure levels are assigned. Scand J Work Environ Health; 26: 37-43.
33. Steenland K, Fletcher T, Savitz DA. (2010) Epidemiologic evidence on the health effects of perfluorooctanoic acid (pfoa). Environ Health Perspect; 118: 1100-8.
34. Steenland K, Jin C, MacNeil J et al. (2009a) Predictors of pfoa levels in a community surrounding a chemical plant. Environ Health Perspect; 117: 1083-8.
35. Steenland K, Tinker S, Frisbee S et al. (2009b) Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol; 170: 1268-78.
36. Symanski E, Greeson NM. (2002) Assessment of variability in biomonitoring data using a large database of biological measures of exposure. AIHA J (Fairfax, Va); 63: 390-401.
37. US EPA. (2005) Draft risk assessment of the potential human health effects associated with exposure to perfluorooctanoic acid and its salts. Washington, DC: U.S. Environmental Protection Agency, Office of Pollution Prevention and Toxics, Risk Assessment Division. Available at http://www.epa.gov/oppt/pfoa/pubs/pfoarisk.pdf. Accessed 20 October 2011.
38. Wu LL, Gao HW, Gao NYet al. (2009) Interaction of perfluorooctanoic acid with human serum albumin. BMC Struct Biol; 9: 31.